AB Science SA
F:A8D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AB Science SA
F:A8D
|
FR |
|
Semen Baturaja (Persero) Tbk PT
IDX:SMBR
|
ID |
|
M
|
Maywood Acquisition Corp
NASDAQ:MAYA
|
US |
|
P
|
Pensionbee Group PLC
F:6HD
|
UK |
|
R
|
Ross Stores Inc
XMUN:RSO
|
US |
|
Cypress Development Corp
XTSX:CYP
|
CA |
|
P
|
Pharmala Biotech Holdings Inc
CNSX:MDMA
|
CA |
|
Garudafood Putra Putri Jaya Tbk PT
IDX:GOOD
|
ID |
|
WASGAU Produktions & Handels AG
F:MSH
|
DE |
|
Sunil Healthcare Ltd
BSE:537253
|
IN |
|
Aifarm Ltd
OTC:AIFM
|
US |
|
O
|
One to One Contacts PCL
SET:OTO
|
TH |
|
E
|
Esso Thailand PCL
SET:ESSO
|
TH |
|
Newpark Resources Inc
NYSE:NR
|
US |
|
Quarta-Rad Inc
OTC:QURT
|
US |
|
Discovery Ltd
F:D3H
|
ZA |
|
Carbeeza Inc
XTSX:AUTO
|
CA |
|
E
|
Edip Gayrimenkul Yatirim Sanayi ve Ticaret AS
IST:EDIP.E
|
TR |
|
D
|
Daiwa Securities Group Inc
DUS:DSE
|
JP |
Bankruptcy Probability
AB Science SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AB Science SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
AB Science SA
PAR:AB
|
53.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
670.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
376.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
246.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
247.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AB Science SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AB Science SA has total debt of 19m EUR. This includes both short-term (2.7m EUR) and long-term (16.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
